GE HealthCare Technologies Inc. (GEHC)
Automate Your Wheel Strategy on GEHC
With Tiblio's Option Bot, you can configure your own wheel strategy including GEHC - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol GEHC
- Rev/Share 43.6893
- Book/Share 21.7768
- PB 3.3456
- Debt/Equity 0.2064
- CurrentRatio 0.9856
- ROIC 0.1046
- MktCap 32461561044.0
- FreeCF/Share 2.6718
- PFCF 26.586
- PE 14.4992
- Debt/Assets 0.0565
- DivYield 0.0019
- ROE 0.2514
- Rating A-
- Score 4
- Recommendation Buy
- P/E Score 3
- DCF Score 4
- P/B Score 2
- D/E Score 2
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Upgrade | GEHC | UBS | Sell | Neutral | -- | $73 | May 5, 2025 |
| Upgrade | GEHC | Goldman | Neutral | Buy | $85 | $100 | March 11, 2025 |
| Upgrade | GEHC | Jefferies | Hold | Buy | $95 | $103 | Jan. 8, 2025 |
| Downgrade | GEHC | UBS | Neutral | Sell | $84 | $74 | Sept. 26, 2024 |
| Upgrade | GEHC | BTIG Research | Neutral | Buy | -- | $100 | Sept. 18, 2024 |
| Initiation | GEHC | JP Morgan | -- | Neutral | -- | $90 | Sept. 9, 2024 |
News
What Makes GE HealthCare (GEHC) a New Strong Buy Stock
Published: August 04, 2025 by: Zacks Investment Research
Sentiment: Positive
GE HealthCare (GEHC) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Read More
GEHC vs. BSX: Which Stock Is the Better Value Option?
Published: August 01, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors interested in Medical - Products stocks are likely familiar with GE HealthCare Technologies (GEHC) and Boston Scientific (BSX). But which of these two stocks is more attractive to value investors?
Read More
GE HealthCare Q2 Earnings & Sales Beat Estimates, Net Margin Rises
Published: July 30, 2025 by: Zacks Investment Research
Sentiment: Positive
GEHC's second-quarter results reflect strength in the Imaging and Pharmaceutical Diagnostics segments. The bottom line improves with better pricing.
Read More
GE HealthCare Technologies Inc. (GEHC) Q2 2025 Earnings Call Transcript
Published: July 30, 2025 by: Seeking Alpha
Sentiment: Neutral
GE HealthCare Technologies Inc. (NASDAQ:GEHC ) Q2 2025 Earnings Conference Call July 30, 2025 8:30 AM ET Company Participants Carolynne Borders - Chief Investor Relations Officer James K. Saccaro - VP & CFO Peter J.
Read More
Compared to Estimates, GE HealthCare (GEHC) Q2 Earnings: A Look at Key Metrics
Published: July 30, 2025 by: Zacks Investment Research
Sentiment: Neutral
While the top- and bottom-line numbers for GE HealthCare (GEHC) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Read More
GE HealthCare Tops Estimates, Lifts Profit Outlook on Smaller Tariff Impact
Published: July 30, 2025 by: Investopedia
Sentiment: Positive
GE HealthCare (GEHC) on Wednesday reported better second-quarter results than analysts had expected and lifted its outlook for the full year.
Read More
GE HealthCare Technologies (GEHC) Q2 Earnings and Revenues Top Estimates
Published: July 30, 2025 by: Zacks Investment Research
Sentiment: Positive
GE HealthCare Technologies (GEHC) came out with quarterly earnings of $1.06 per share, beating the Zacks Consensus Estimate of $0.91 per share. This compares to earnings of $1 per share a year ago.
Read More
GE HealthCare Stock Rises as Earnings Beat. How Tariff Pressures Are Easing.
Published: July 30, 2025 by: Barrons
Sentiment: Positive
Wednesday, GE HealthCare reported earnings per share of $1.06 from sales of just over $5 billion. Wall Street was looking for EPS of 92 cents from sales of just under $5 billion.
Read More
GE HealthCare reports second quarter 2025 financial results
Published: July 30, 2025 by: Business Wire
Sentiment: Neutral
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today reported financial results for the second quarter ended June 30, 2025. GE HealthCare President and CEO Peter Arduini said, “We were pleased with solid orders and revenue performance in the second quarter across all segments, reflecting healthy customer investment in capital equipment. We also reported strong earnings performance while leveraging our lean capabilities and demonstrating progress on tariff mitigation. Overall, we believe.
Read More
Should You Buy, Sell, or Hold GE Healthcare Before Q2 Earnings?
Published: July 28, 2025 by: Zacks Investment Research
Sentiment: Neutral
GEHC leans on Imaging and PDx strength for Q2, but tariff headwinds and margin pressures could test investor confidence.
Read More
GE HealthCare launches new advanced digital X-ray system to enable access and increase efficiency in high throughput settings
Published: July 24, 2025 by: Business Wire
Sentiment: Neutral
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC), today announced commercial availability of an advanced floor-mounted digital X-ray system, Definium™ Pace Select ET1, designed to deliver high-image quality and optimize efficiency in highly demanding environments while enhancing access and affordability. X-ray exams often serve as the entry point to diagnostic imaging, accounting for 60% of all imaging studies conducted, resulting in an ever-increasing workload for radiologists and techno.
Read More
GE HealthCare Stock: Hidden Winner Of Alzheimer's Drug Boom
Published: July 21, 2025 by: Seeking Alpha
Sentiment: Positive
GE HealthCare Technologies is one of the leaders in the healthcare sector, with a strong position in the global molecular imaging market. GE HealthCare's Pharmaceutical Diagnostics segment's EBIT was $205 million in Q1 2025, up 15.2% year over year. I expect it to rise to $245 million in Q2, driven by increased sales of Vizamyl, which is used to prescribe anti-amyloid drugs for the treatment of Alzheimer's disease.
Read More
3 AI-Driven Medical Device Stocks to Watch in 2025
Published: July 11, 2025 by: Zacks Investment Research
Sentiment: Positive
BSX, JNJ and GEHC are leveraging AI to boost device performance, diagnostics and surgical precision in 2025.
Read More
SNN vs. GEHC: Which Stock Is the Better Value Option?
Published: June 25, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors interested in Medical - Products stocks are likely familiar with Smith & Nephew (SNN) and GE HealthCare Technologies (GEHC). But which of these two stocks is more attractive to value investors?
Read More
GEHC Stock Gains Post FDA's Nod for Vizamyl's Expanded Indications
Published: June 25, 2025 by: Zacks Investment Research
Sentiment: Positive
GE HealthCare gains FDA nod to expand Vizamyl's use, unlocking new diagnostic and therapy-monitoring capabilities.
Read More
GE HealthCare's Flyrcado Sets New Benchmark in Cardiac PET Imaging
Published: June 24, 2025 by: Zacks Investment Research
Sentiment: Positive
GEHC's Flyrcado gains momentum with FDA approval, CMS support, and expanding coverage in cardiac PET imaging.
Read More
GE HealthCare enhances cardiac diagnostics with innovative molecular imaging solutions showcased at SNMMI 2025
Published: June 23, 2025 by: Business Wire
Sentiment: Neutral
CHICAGO--(BUSINESS WIRE)--GE HealthCare's commitment to advancing precision care in cardiology through innovative molecular imaging solutions is on full display at this week's Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting in New Orleans, Louisiana. As cardiovascular disease (CVD) continues to rise globally,i the need for advanced diagnostic technologies becomes increasingly critical. GE HealthCare's molecular imaging technologies – including positron emission tomograp.
Read More
Pioneering precision: GE HealthCare aims to elevate clinical care through total body PET/CT technology with Stanford Medicine
Published: June 19, 2025 by: Business Wire
Sentiment: Neutral
CHICAGO--(BUSINESS WIRE)--Building on a collaboration that spans more than three decades, GE HealthCare has renewed its research collaboration with Stanford Medicine – with one of their key intentions being the development and research of innovative total body PET/CT technology.i This effort is expected to explore new clinical pathways and help enhance patient outcomes through innovative imaging solutions. “PET/CT has revolutionized the way we understand and treat disease by allowing us to visu.
Read More
GE HealthCare Stock Slips Despite the Launch of bkActiv S Series
Published: June 18, 2025 by: Zacks Investment Research
Sentiment: Neutral
GEHC expands its bkPortfolio with the AI-powered bkActiv S Series to advance ultrasound-guided procedures.
Read More
GEHC Stock Declines Despite Expansion in Precision Care Capabilities
Published: June 16, 2025 by: Zacks Investment Research
Sentiment: Neutral
GE HealthCare integrates proprietary algorithms into MIM Encore to advance digital imaging and workflow precision.
Read More
GE HealthCare: The Demand Is Just Too Strong To Ignore
Published: June 04, 2025 by: Seeking Alpha
Sentiment: Positive
GE HealthCare's diverse business model, strong demand, and leadership in key segments position it well for long-term growth, especially with an aging population tailwind. Recent tariff volatility has pressured margins and guidance, but GEHC's global supply chain efficiency and margin recovery potential remain attractive for patient investors. Valuation is compelling at 17x forward PE, with buybacks and robust demand supporting an 18% CAGR outlook to 2029, signaling strong upside potential.
Read More
3 Things Nvidia Management Just Said That Build the Buy Case for These 3 Magnificent Hidden AI Stocks
Published: June 04, 2025 by: The Motley Fool
Sentiment: Neutral
Nvidia's (NVDA 0.51%) recent earnings report boosted the market and alleviated concerns about any slowdown in artificial intelligence (AI) and data-center-related spending. That's great news for Nvidia and other frontline players in the AI/data center industry.
Read More
PharmaLogic Announces Appointment of Etienne Montagut as President and Chief Executive Officer
Published: June 02, 2025 by: PRNewsWire
Sentiment: Neutral
BOCA RATON, Fla. , June 2, 2025 /PRNewswire/ -- PharmaLogic Holdings Corp.
Read More
GEHC Stock May Rise Following the Launch of AI-Based CleaRecon DL
Published: May 16, 2025 by: Zacks Investment Research
Sentiment: Positive
GE HealthCare launches CleaRecon DL, an AI-powered 3D imaging tech that enhances cone-beam CT scans by reducing artifacts, improving clarity for better interventional care.
Read More
GE HealthCare Stock May Gain as FDA Approves Optison for Pediatric Use
Published: May 15, 2025 by: Zacks Investment Research
Sentiment: Positive
GEHC's Optison ultrasound agent receives FDA approval for pediatric use, improving echocardiogram clarity and advancing heart diagnostics for children with safer imaging.
Read More
GEHC Stock Surges as SIGNA Sprint MRI Redefines 1.5T Imaging Tech
Published: May 13, 2025 by: Zacks Investment Research
Sentiment: Positive
GE HealthCare unveils SIGNA Sprint MRI, a high-performance 1.5T system designed to boost diagnostic accuracy, accelerate imaging, and advance cardiac and cancer care.
Read More
ESTRO 2025 Congress: GE HealthCare to expand its radiation oncology portfolio and introduce new AI-enabled solutions
Published: May 02, 2025 by: Business Wire
Sentiment: Neutral
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced an intended expansion of its radiation oncology portfolio as well as the introduction of the new AI-enabled MR Contour DL™ at the European Society for Therapeutic Radiology and Oncology (ESTRO) 2025 Congress in Vienna, Austria. The company will also showcase its updated Intelligent Radiation Therapy (iRT), a software solution that standardizes complex workflows, helping to enable a shorter timeline from diagnosis to treatmen.
Read More
GE Healthcare sees tariffs costing $500 million in 2025, then much less next year
Published: April 30, 2025 by: Market Watch
Sentiment: Negative
GE Healthcare sees bilateral China tariffs accounting for most of the expected tariff cost, or roughly 75%.
Read More
GE HealthCare Q1 Earnings & Sales Beat Estimates, Net Margin Rises
Published: April 30, 2025 by: Zacks Investment Research
Sentiment: Positive
GEHC's first-quarter results reflect strength in the Imaging and Pharmaceutical Diagnostics segments. The bottom line improves on better pricing.
Read More
GE HealthCare Technologies Inc. (GEHC) Q1 2025 Earnings Call Transcript
Published: April 30, 2025 by: Seeking Alpha
Sentiment: Neutral
GE HealthCare Technologies Inc. (NASDAQ:GEHC ) Q1 2025 Earnings Conference Call April 30, 2025 8:30 AM ET Company Participants Carolynne Borders - Chief Investor Relations Officer Peter Arduini - President and Chief Executive Officer Jay Saccaro - Vice President and Chief Financial Officer Conference Call Participants Larry Biegelsen - Wells Fargo Jason Bednar - Piper Sandler Vijay Kumar - Evercore ISI Robbie Marcus - JPMorgan David Roman - Goldman Sachs Joanne Wuensch - Citi Craig Bijou - BofA Securities Anthony Petrone - Mizuho Financial Group Operator Good day, and thank you for standing by. Welcome to the GE HealthCare First …
Read More
About GE HealthCare Technologies Inc. (GEHC)
- IPO Date 2022-12-15
- Website https://www.gehealthcare.com
- Industry Medical - Healthcare Information Services
- CEO Peter J. Arduini
- Employees 53000